| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/2001 | EP1130964A1 Therapeutic anti-fungal nail preparation |
| 09/12/2001 | EP1044200A4 Preparation of terazosin hydrochloride dihydrate |
| 09/12/2001 | EP1032424B1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
| 09/12/2001 | EP1000065A4 Preparation of oxymorphone, oxycodone and derivatives |
| 09/12/2001 | EP0991424B1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 09/12/2001 | EP0915845B1 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 09/12/2001 | EP0891354B1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 09/12/2001 | EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 09/12/2001 | EP0883596B1 Fluorinated propranolol and related methods |
| 09/12/2001 | EP0882030B1 2,1,3-benzothia(oxa)diazole derivatives having an endothelin receptor antagonistic effect |
| 09/12/2001 | EP0880366B1 Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-beta-estradiol to the human organism |
| 09/12/2001 | EP0843680B1 Process for the preparation of potassium clavulanate |
| 09/12/2001 | EP0839206B1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 09/12/2001 | EP0832649B1 Antifungal agent |
| 09/12/2001 | EP0832066B1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 09/12/2001 | EP0831864B1 Processed ginseng having enhanced pharmacological effect |
| 09/12/2001 | EP0820450B1 N-substituted azaheterocyclic carboxylic acids and alkylesters thereof |
| 09/12/2001 | EP0817775B1 Quinazoline derivatives |
| 09/12/2001 | EP0814788B1 Improving glucose tolerance |
| 09/12/2001 | EP0809627B1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use |
| 09/12/2001 | EP0793665B1 Heterocyclic compounds and their preparation and use |
| 09/12/2001 | EP0790987B1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 09/12/2001 | EP0788349B1 Liposome composition containing selegilin |
| 09/12/2001 | EP0782855B1 Nimesulide for external use |
| 09/12/2001 | EP0764177B1 Crosslinked polymer containing composition for removing bile salts from a patient |
| 09/12/2001 | EP0749424B1 Naphthalene derivatives as prostaglandin i2 agonists |
| 09/12/2001 | EP0682514B1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
| 09/12/2001 | EP0644878B1 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ b]AZEPINES AS NMDA RECEPTOR ANTAGONISTS |
| 09/12/2001 | EP0630240B1 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists |
| 09/12/2001 | EP0629203B1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 09/12/2001 | EP0586474B1 Peptide nucleic acids |
| 09/12/2001 | EP0449856B1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 09/12/2001 | CN1312856A Enzymatic nucleic acid treamtent of diseases or conditions related to hepatitisc virus infection |
| 09/12/2001 | CN1312813A Therapeutic agents |
| 09/12/2001 | CN1312812A Muscarinic agonists and antagonists |
| 09/12/2001 | CN1312810A Substituted 1,8-naphthyridin-4(1H)-ones as phosphodiesterase 4 inhibitors |
| 09/12/2001 | CN1312809A N-substituted azabicycloheptane deriratives, production and use thereof |
| 09/12/2001 | CN1312808A N-Substituted azabicycloheptane derivatives, production and use thereof |
| 09/12/2001 | CN1312807A Inhibitors of glycogen synthase kinase 3 |
| 09/12/2001 | CN1312806A Prodrugs of proton pump inhibitors |
| 09/12/2001 | CN1312805A Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 09/12/2001 | CN1312804A Macrocyclic analogs and methods of their use and preparation |
| 09/12/2001 | CN1312803A Novel benzopykan or thiobenzopyran derivatives |
| 09/12/2001 | CN1312802A Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 09/12/2001 | CN1312800A Therapeutic biaryl derivatives |
| 09/12/2001 | CN1312799A Bispiperidines as antithrombotic agents |
| 09/12/2001 | CN1312796A 5-thia-omega-substituted phenyl-prostaglandin E derivatives, process for producing same and drugs containing same as active ingredient |
| 09/12/2001 | CN1312795A New 3-aryl propionic acid derivatives and analogs |
| 09/12/2001 | CN1312794A Benflumetol, intermediates thereof and their use against parasitical protozoa and trematodes |
| 09/12/2001 | CN1312729A Dry powder dispersing apparatus and method therefor |
| 09/12/2001 | CN1312722A Compounds obtained from i(salvia) species having antiviral activity |
| 09/12/2001 | CN1312719A Pharmaceutical Composition |
| 09/12/2001 | CN1312718A Selective estrogen receptor modulator in combination with sex steriod precursors and the like |
| 09/12/2001 | CN1312717A Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| 09/12/2001 | CN1312716A Use of optically pure (-)-norcisapride in treatment of apnea, bulimta and other disorders |
| 09/12/2001 | CN1312715A Antihypersensitive combination of valsartan and calcium channel blocker |
| 09/12/2001 | CN1312714A Pharmaceutical composition containing lipase inhibitors and chitosan |
| 09/12/2001 | CN1312713A Pharmaceutical compositions containing lipase inhibitors |
| 09/12/2001 | CN1312712A Therapeutic composition based on flavonoids for use in treatment of tumours with cytotoxic agents |
| 09/12/2001 | CN1312711A Medicinal compositions for treating evacuatory insufficiency |
| 09/12/2001 | CN1312708A Process of generating submicron particles of water-insuluble compounds |
| 09/12/2001 | CN1312706A Medicinal aerosol for mulations |
| 09/12/2001 | CN1312685A 碳水化合物混合物 Carbohydrate blend |
| 09/12/2001 | CN1312372A Intocostrin regulation area and nucleotide series determination and method used thereof |
| 09/12/2001 | CN1312297A Extraction method of BG polysaccharide as hemostatic material |
| 09/12/2001 | CN1312294A Human blood and blood vessel cytopoiesis hormone and its preparation |
| 09/12/2001 | CN1312254A Novel nucleoside |
| 09/12/2001 | CN1312253A Radde anemone rhizome extract and its prepn process and use |
| 09/12/2001 | CN1312251A Preparation of partially synthesized deuteroporphyrin derivative and its freeze dried injection |
| 09/12/2001 | CN1312246A Process for preparing carboxylic acid |
| 09/12/2001 | CN1312150A Process for high polymer synthesis to phenol compounds and the like and use thereof |
| 09/12/2001 | CN1312110A Chinese medicine preparation for treating infant pulmonitis and dyspneic cough |
| 09/12/2001 | CN1312105A External-use liposome prepn for treating mite-borne dermatosis |
| 09/12/2001 | CN1312093A Medicine composition for treating woman's sexual function disease |
| 09/12/2001 | CN1312092A Rheumatism treating oral capsule and plaster and their preparation method |
| 09/12/2001 | CN1312091A Vaginitis treating medicine |
| 09/12/2001 | CN1312082A Leukoderma curing plaster |
| 09/12/2001 | CN1312079A Nasosinusitis treating medicine |
| 09/12/2001 | CN1312078A Making process of compound sulfadiazine zinc spreader |
| 09/12/2001 | CN1312077A Composite component comprising the effective extracts of licorice and lightyellow sophora and its application |
| 09/12/2001 | CN1312076A External-use and eye ofloxacin zinc preparation |
| 09/12/2001 | CN1312075A Lipid-matabolizing improvement agent |
| 09/12/2001 | CN1312074A New application of benzene ring pelargonate hydrochloride |
| 09/12/2001 | CN1312073A New application of benzene ring pelargonate hydrochloride |
| 09/12/2001 | CN1312072A Medicine composition for treating hepatocellular carcinoma |
| 09/12/2001 | CN1312071A Linolic acid and linolenic acid capsule and its making process |
| 09/12/2001 | CN1312070A Application of cinnamic acid, cinnamate and their derivative in preparing medicine |
| 09/12/2001 | CN1312065A Use of compound for improving skin and its mucous membrane physical-chemical property to prevent adsorption of microorganism |
| 09/12/2001 | CN1070864C Process for preparation of erythromycin |
| 09/12/2001 | CN1070859C 6-methoxy-1H-benzotriazole-5-carboxamide derivatives, process for producing same, and medicinal composition containing same |
| 09/12/2001 | CN1070853C 10-acyloxy-10,11-dihydrodibenz/b,f/azepine-5-carboxamides useful for treating nervous system disorders |
| 09/12/2001 | CN1070852C Process for preparing 14-o-acylate of aconite alkaloid type compounds |
| 09/12/2001 | CN1070850C Novel carbamate compounds containing thiocarbamoyl group and process for preparing same |
| 09/12/2001 | CN1070849C Enzyme inhibitors |
| 09/12/2001 | CN1070841C Carboxylic acid derivatives, their preparation and their use |
| 09/12/2001 | CN1070703C Preparation of fusidic acid tablets |
| 09/12/2001 | CN1070702C Use of 2,4-diamino pyrimidine 3-oxide or its salt thereof for treating collegen maturation and structuring disorders |
| 09/12/2001 | CN1070701C Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments |
| 09/12/2001 | CN1070700C Process for preparation of medicine containing flupirtine and use to combat muscular tension thereof |
| 09/12/2001 | CN1070699C Topical composition comprising N-acetye-L-cysteine |